About this trial
This clinical trial evaluates the effects of whether breathing exercises at home can reduce symptoms and help stage I-III lung cancer survivors stay active. Over 70% of lung cancer survivors have trouble breathing, feel tired, and have lower levels of fitness. This is often because their breathing muscles are weaker after surgery. Many survivors find it hard to exercise, which affects their quality of life and overall survival. A training program to strengthen these muscles might reduce breathing problems, lower fatigue, and improve quality of life. Staying active could also help boost the immune system to fight cancer. Respiratory muscle training (RMT) involves a series of breathing and other exercises that are performed to improve the function of the respiratory muscles through resistance and endurance training. Participating in a home-based RMT intervention may reduce symptoms from cancer or treatment in lung cancer survivors.
Eligibility criteria
Qualifiers
Age ≥ 18 years of age.
Able to speak, read and comprehend the English language
Self-identify as non-Hispanic Black or White.
Are < 24 months of histologically confirmed invasive, non-metastatic, lung cancer diagnosis.
Disqualifiers
Participant has in situ (stage 0) or metastatic (stage IV) disease at study entry.
Has contraindications for respiratory muscle training (e.g., recent pulmonary embolism, aortic aneurysm, current pneumothorax).
Is actively engaging in a structured exercise program and/or meeting exercise guidelines.
Unwilling or unable to follow protocol requirements.
Trial design
Treatments tested in this trial
- Biospecimen Collection
- Electronic Health Record Review
- Medical Device Usage and Evaluation
- Questionnaire Administration
- Respiratory Muscle Training
- Sham Intervention